Scientific Program
Time | Topic and Speaker |
---|---|
08:30 - 09:00 | Registration |
09:00 - 09:05 | Opening Remarks Lawrence Gan, Ph.D Director of Taiwan Antibody Association; President/CEO, Foresee Pharmaceuticals |
09:05 - 09:10 | Herbert Wu, Ph.D. President, Development Center for Biotechnology |
Opening Keynote | |
Moderator 09:10 - 09:15 |
Yun Yen, M.D., Ph.D. President Emeritus of Taipei Medical University, Chair Professor of the Ph.D. Program for Cancer Biology and Drug Discovery |
09:15 - 10:00 | Cancer Cell Cast a Sweet Spell on Tumor Microenvironment: Opportunities and Challenges Alice Yu, M.D., Ph.D. Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital |
10:00 - 10:30 | Break |
Moderator 10:30 - 10:35 |
Shie-Liang Edmond Hsieh, M.D., D.Phil. Distinguished Research Fellow, Genomics Research Center, Academia Sinica |
10:35 - 11:05 | Defining the Difference: Developing Translational Screening Models to Mimic Tumor Microenvironment Litao Zhang, Ph.D. VP, Leads Discovery & Optimization R&D, Bristol-Myers Squibb |
11:05 - 11:35 | What You Eat Makes You Strong but Vulnerable : Metabolic Targeting of Intramural Tregs in Cancer Immunotherapy Ping-Chih Ho, Ph.D. Assistant Professor/Ludwig adjunct scientist Department of oncology UNIL CHUV/Ludwig Institute for Cancer Research Lausanne |
11:35 - 12:05 | Finding Better Combinations of Immunotherapy Keng-Li Lan, M.D., Ph.D. Associate Professor, Institute of Traditional Medicine, School of Medicine, National Yang-Ming University;Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital |
12:05 - 13:40 | Lunch (Taiwan Antibody Association Members Meeting and Poster Viewing) |
12:15 - 12:45 | Lunch Panel / Industry satellite symposium |
Moderator 13:40 - 13:45 |
Ping-Ning Hsu, M.D., Ph.D. Professor, Graduate Institute of Immunology, College of Medicine, National Taiwan University |
13:45 - 14:15 | Understanding Immune Checkpoint TIM-3 Biology and TIM-3 Antibody for Cancer Immunotherapy Xiaomo Jiang , Ph.D. Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research |
14:15 - 14:45 | Clinical Experience and Safety Management of Immunotherapy John Wen-Cheng Chang, M.D. Chief, Division of Medical Oncology, Chang Gung Memorial Hospital; Director, Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital; Chairman, Taiwan Society for Immunotherapy of Cancer |
14:45 - 15:15 | Current Progress of Immunotherapy for Non-small Cell Lung Cancer Chih-Hsin Yang, M.D., Ph.D. Professor & Director, Graduate Institute of Oncology, College of Medicine, National Taiwan University |
15:15 - 15:45 | Break |
15:45 - 16:00 | Poster Award |
Closing Keynote | |
Moderator 16:00 - 16:05 |
Herbert Wu, Ph.D. President, Development Center for Biotechnology |
16:05 - 16:50 | Engineering Adaptive Cell and Gene Therapies Timothy K. Lu, Ph.D. Associate Professor Synthetic Biology Group, Research Laboratory of Electronics, Electrical Engineering and Computer Science, Biological Engineering, Massachusetts Institute of Technology |
16:50 - 17:00 | Closing Remarks Herbert Wu, Ph.D. President, Development Center for Biotechnology |